Extremely important positive changes in investment behavior have recently occurred for Fennec Pharmaceuticals Inc (NASDAQ: FENC): positive upside/downside volume developed, its shorter term price trend turned up, and the stock rose on very heavy volume.
Fennec Pharmaceuticals Inc (NASDAQ: FENC). Small positive changes in fundamentals have recently occurred: the consensus estimate for December, 2024 increased significantly.
The stock is currently unrated.
Current PriceTarget Research Rating
FENC is expected to be a major Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Fennec Pharmaceuticals is currently unrated.
Recent Price Action
Fennec Pharmaceuticals Inc (NASDAQ: FENC) stock rose modestly by 0.9% on 11/16/23. The stock closed at $8.08. The stock has risen 6.0% during the last week and has performed in line with the market over the last nine months.
Be the first to comment